About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Liver Diseases group is a referent at the local, national and international level in research, and is one of the most active groups in clinical research at VHIR. The group's prominent involvement in clinical trials is a clear indication of our professionals' commitment to ensuring that patients have access to state-of-the-art therapies. Our participation and collaboration in international projects and consortiums are also a fundamental characteristic of the group. The main objective of the group is to become one of the best translational research groups in liver diseases. It is essential to be able to apply all the findings of basic research to clinical research to improve the health of patients with liver disease.
PMID: 34554648 Journal: AMERICAN JOURNAL OF TRANSPLANTATION Year: 2022 Reference: Am J Transplant. 2022 Feb;22(2):673-675. doi: 10.1111/ajt.16855. Epub 2021 Oct 5. Impact factor: Publication type: Letter or abstract Authors: Bestard, Oriol; Campins, Magda; Campos-Varela, Isabel; Castells, Lluis; Crespo, Elena; Esperalba, Juliana; Jouve, Thomas; Len, Oscar; Lopez, Manuel; Moreso, Francesc et al. DOI: 10.1111/ajt.16855
PMID: 35101740 Journal: SOCIAL SCIENCE & MEDICINE Year: 2022 Reference: Soc Sci Med. 2022 Mar;296:114733. doi: 10.1016/j.socscimed.2022.114733. Epub 2022 Jan 22. Impact factor: Publication type: Review in international publication Authors: Benach, Joan; Gutierrez, Manuela; Gutierrez-Zamora Navarro, Mariana; Martinez-Herrera, Eliana; Molina-Betancur, Juan Camilo; Padilla-Pozo, Alvaro; Pericas, Juan M; Zografos, Christos et al. DOI: 10.1016/j.socscimed.2022.114733
PMID: 35092743 Journal: JOURNAL OF HEPATOLOGY Year: 2022 Reference: J Hepatol. 2022 May;76(5):1042-1050. doi: 10.1016/j.jhep.2022.01.007. Epub 2022 Jan 29. Impact factor: Publication type: Paper in international publication Authors: Agarwal, K; Ahn, S H; Berg, T; Boonstra, A; Brakenhoff, S M; Buti, M; Carey, I; Chen, C-H; Chiu, S-M; Cornberg, M et al. DOI: 10.1016/j.jhep.2022.01.007
PMID: 35074352 Journal: ENVIRONMENTAL RESEARCH Year: 2022 Reference: Environ Res. 2022 May 15;208:112720. doi: 10.1016/j.envres.2022.112720. Epub 2022 Jan 22. Impact factor: Publication type: Paper in international publication Authors: Andres, Cristina; Anton, Andres; Borrego, Carles M; Bosch, Albert; Carcereny, Albert; Chacon-Villanueva, Carme; Garcia-Cehic, Damir; Garcia-Pedemonte, David; Gregori, Josep; Guix, Susana et al. DOI: 10.1016/j.envres.2022.112720
PMID: 32980344 Journal: GASTROENTEROLOGY Year: 2021 Reference: Gastroenterology. 2021 Jan;160(1):193-205.e10. doi: 10.1053/j.gastro.2020.09.026. Epub 2020 Sep 24. Impact factor: Publication type: Paper in international publication Authors: Abraldes, Juan G; Albillos, Agustin; Alexandrino, Paula; Allegretti, Giulia; Alvarado, Edilmar; Amitrano, Lucio; Angrisani, Debora; Appenrodt, Beate; Augustin, Salvador; Bai, Wei et al. DOI: 10.1053/j.gastro.2020.09.026
PMID: 32941394 Journal: TRANSPLANTATION Year: 2021 Reference: Transplantation. 2021 Jan 1;105(1):138-150. doi: 10.1097/TP.0000000000003460. Impact factor: Publication type: Paper in international publication Authors: Alonso-Martinez, Carla; Anton, Andres; Berastegui, Cristina; Castells, Lluis; Del-Rio-Gutierrez, Jose-Manuel; Domenech, Laura; Garcia-Garcia, Sonia; Garcia-Ortega, Patricia; Gomez-Ganda, Laura; Gorgas-Torner, Maria-Queralt et al. DOI: 10.1097/TP.0000000000003460
PMID: 32896580 Journal: JOURNAL OF HEPATOLOGY Year: 2021 Reference: J Hepatol. 2021 Jan;74(1):200-219. doi: 10.1016/j.jhep.2020.08.009. Epub 2020 Sep 5. Impact factor: Publication type: Paper in international publication Authors: Aban, M; Abraldes, J G; Alessandria, C; Avitabile, E; Bernardi, M; Beuers, U; Campion, D; Caraceni, P; Carol, M; Cervera, M et al. DOI: 10.1016/j.jhep.2020.08.009
PMID: 32750442 Journal: JOURNAL OF HEPATOLOGY Year: 2021 Reference: J Hepatol. 2021 Jan;74(1):148-155. doi: 10.1016/j.jhep.2020.07.040. Epub 2020 Aug 1. Impact factor: Publication type: Paper in international publication Authors: Alamo, Jose Maria; Arias-Milla, Ana; Blanco-Fernandez, Gerardo; Bustamante-Schneider, Javier; Caballero, Aranzazu; Cachero, Alba; Castells, Lluis; Colmenero, Jordi; De la Rosa, Gloria; Fabrega, Emilio et al. DOI: 10.1016/j.jhep.2020.07.040
PMID: 32752979 Journal: Emerging Microbes & Infections Year: 2020 Reference: Emerg Microbes Infect. 2020 Dec;9(1):1900-1911. doi: 10.1080/22221751.2020.1806735. Impact factor: 5.776 Publication type: Paper in international publication Authors: Almirante, Benito, Esteban, Juan Ignacio, Pumarola, Tomas, Anton, Andres, Quer, Josep, Ferrer, Ricard, Campins, Magda, Martin, Maria Carmen, Quer, Susanna, Andres, Cristina et al. DOI: 10.1080/22221751.2020.1806735
PMID: 32711039 Journal: JOURNAL OF INFECTION Year: 2020 Reference: J Infect. 2020 Oct;81(4):600-606. doi: 10.1016/j.jinf.2020.07.019. Epub 2020 Jul 22. Impact factor: 4.842 Publication type: Paper in international publication Authors: Fernandez-Cuenca, Felipe, Garcia-Arata, Isabel, Reina, Gabriel, Ocete, Maria Dolores, Fuentes, Ana, de la Cruz, Daniel Navarro, Nieto, Leonardo, de Castro, Ana Blazquez, Buti, Maria, Alvarez, Marta et al. DOI: 10.1016/j.jinf.2020.07.019
PMID: 32703729 Journal: DIGESTIVE AND LIVER DISEASE Year: 2020 Reference: Dig Liver Dis. 2020 Oct;52(10):1164-1169. doi: 10.1016/j.dld.2020.06.037. Epub 2020 Jul 20. Impact factor: 3.57 Publication type: Paper in international publication Authors: Roade, Luisa, Loglio, Alessandro, Borghi, Marta, Riveiro-Barciela, Mar, Soffredini, Roberta, Facchetti, Floriana, di Paolo, Dhanai, Tabernero, David, Lunghi, Giovanna, Esteban, Rafael et al. DOI: 10.1016/j.dld.2020.06.037
PMID: 32697274 Journal: Revista espanola de sanidad penitenciaria Year: 2020 Reference: Rev Esp Sanid Penit. 2020 May-Aug;22(2):55-57. doi: 10.18176/resp.00010. Impact factor: 0 Publication type: Editorail in international publication Authors: Rivera Esteban, J M, Augustin Recio, S et al. DOI: 10.18176/resp.00010
The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.
Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.
On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.
Des de Vall d'Hebron estem buscant 200 persones voluntàries sanes d'entre 18 i 30 anys per a participar en un estudi sobre els patrons de consum habitual de l'alcohol en població jove, en el marc del projecte StopALD.
